Treating Disease by Editing Genes in the Microbiome
The Bio Report
00:00
Acne, Is It a Problem for You?
Last year, you mentioned that eligo entered into a research and option agreement with g s k to develop a crisper based approach to treating acney. This's a deal worth up to 224 million in license fees and potential milestones, as well as royalties on sales. Most of the hackne are drugs available in the market; they only provide symptomatic treatment, and they really don't cure the condition. There is also no treatment in the market that address this acne associative despises.
Play episode from 24:16
Transcript
